Literature DB >> 16415001

Effects of Gag mutation and processing on retroviral dimeric RNA maturation.

William Fu1, Que Dang, Kunio Nagashima, Eric O Freed, Vinay K Pathak, Wei-Shau Hu.   

Abstract

After their release from host cells, most retroviral particles undergo a maturation process, which includes viral protein cleavage, core condensation, and increased stability of the viral RNA dimer. Inactivating the viral protease prevents protein cleavage; the resulting virions lack condensed cores and contain fragile RNA dimers. Therefore, protein cleavage is linked to virion morphological change and increased stability of the RNA dimer. However, it is unclear whether protein cleavage is sufficient for mediating virus RNA maturation. We have observed a novel phenotype in a murine leukemia virus capsid mutant, which has normal virion production, viral protein cleavage, and RNA packaging. However, this mutant also has immature virion morphology and contains a fragile RNA dimer, which is reminiscent of protease-deficient mutants. To our knowledge, this mutant provides the first evidence that Gag cleavage alone is not sufficient to promote RNA dimer maturation. To extend our study further, we examined a well-defined human immunodeficiency virus type 1 (HIV-1) Gag mutant that lacks a functional PTAP motif and produces immature virions without major defects in viral protein cleavage. We found that the viral RNA dimer in the PTAP mutant is more fragile and unstable compared with those from wild-type HIV-1. Based on the results of experiments using two different Gag mutants from two distinct retroviruses, we conclude that Gag cleavage is not sufficient for promoting RNA dimer maturation, and we propose that there is a link between the maturation of virion morphology and the viral RNA dimer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415001      PMCID: PMC1346957          DOI: 10.1128/JVI.80.3.1242-1249.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein.

Authors:  B Kattenbeck; A von Poblotzki; A Rohrhofer; H Wolf; S Modrow
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

2.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.

Authors:  W H Zhang; D J Hockley; M V Nermut; Y Morikawa; I M Jones
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

4.  The morphology of the immature HIV-1 virion.

Authors:  A Ohagen; R B Luftig; A S Reicin; L Yin; K Ikuta; T Kimura; S P Goff; S Höglund
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

5.  The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo.

Authors:  L Willems; P Kerkhofs; L Attenelle; A Burny; D Portetelle; R Kettmann
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

6.  Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

Authors:  U K von Schwedler; T L Stemmler; V Y Klishko; S Li; K H Albertine; D R Davis; W I Sundquist
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

7.  Structure of the amino-terminal core domain of the HIV-1 capsid protein.

Authors:  R K Gitti; B M Lee; J Walker; M F Summers; S Yoo; W I Sundquist
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

8.  Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.

Authors:  N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses.

Authors:  K Alin; S P Goff
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

10.  Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.

Authors:  M Yeager; E M Wilson-Kubalek; S G Weiner; P O Brown; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  16 in total

Review 1.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing.

Authors:  Stéphan Maurel; Laurent Houzet; Eric L Garcia; Alice Telesnitsky; Marylène Mougel
Journal:  RNA       Date:  2007-10-10       Impact factor: 4.942

3.  Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins.

Authors:  Sook-Kyung Lee; Vitaly Boyko; Wei-Shau Hu
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

4.  Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain.

Authors:  Cristina Gherghe; Christopher W Leonard; Robert J Gorelick; Kevin M Weeks
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Authors:  Olga A Nikolaitchik; Robert J Gorelick; Maria G Leavitt; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

6.  Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.

Authors:  Michael D Moore; William Fu; Ferri Soheilian; Kunio Nagashima; Roger G Ptak; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

Review 7.  FIV Gag: virus assembly and host-cell interactions.

Authors:  Benjamin G Luttge; Eric O Freed
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

8.  Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

Authors:  Lisa Z Scheifele; Scott P Kenney; Tina M Cairns; Rebecca C Craven; Leslie J Parent
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

Review 9.  HIV-1 RNA dimerization: It takes two to tango.

Authors:  Michael D Moore; Wei Shau Hu
Journal:  AIDS Rev       Date:  2009 Apr-Jun       Impact factor: 2.500

10.  The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity.

Authors:  Masahisa Ohishi; Takashi Nakano; Sayuri Sakuragi; Tatsuo Shioda; Kouichi Sano; Jun-ichi Sakuragi
Journal:  Nucleic Acids Res       Date:  2010-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.